Practical approach to the identification of clinically relevant Enterococcus species
- 25 June 1999
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 34 (3) , 165-171
- https://doi.org/10.1016/s0732-8893(99)00032-2
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Antimicrobial Activity of Quinupristin-Dalfopristin (RP 59500, Synercid®) Tested against Over 28,000 Recent Clinical Isolates from 200 Medical Centers in the United States and CanadaDiagnostic Microbiology and Infectious Disease, 1998
- Laboratory Methods for Surveillance of Vancomycin-Resistant EnterococciClinical Microbiology Newsletter, 1998
- VANCOMYCIN-RESISTANT ENTEROCOCCUS: Detection, Epidemiology, and Control MeasuresInfectious Disease Clinics of North America, 1997
- Provisional interpretive criteria for quinupristin/dalfopristin susceptibility tests.Journal of Antimicrobial Chemotherapy, 1997
- Activity of the quinupristin-dalfopristin combination (RP-59500; Synercid) tested against vancomycin-resistant Enterococcus speciesDiagnostic Microbiology and Infectious Disease, 1996
- Evalution of Vitek and API 20S for species identification of enterococciDiagnostic Microbiology and Infectious Disease, 1995
- Emerging multiply resistant enterococci among clinical isolates II. Validation of the Etest to recognize glycopeptide-resistant strainsDiagnostic Microbiology and Infectious Disease, 1995
- In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organismsAntimicrobial Agents and Chemotherapy, 1993
- In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococciAntimicrobial Agents and Chemotherapy, 1991
- Molecular epidemiology of beta-lactamase-producing enterococciAntimicrobial Agents and Chemotherapy, 1990